HER2-positive

Clinical trials for HER2-positive explained in plain language.

Never miss a new study

Get alerted when new HER2-positive trials appear

Sign up with your email to follow new studies for HER2-positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug zanidatamab aims to shrink early breast cancer tumors before surgery

Disease control Recruiting now

This phase 2 trial is testing a drug called zanidatamab in 20 people with early-stage, low-risk HER2-positive breast cancer. The drug is given intravenously, along with hormone therapy pills (letrozole or tamoxifen). The main goal is to see if the cancer disappears completely by …

Matched conditions: HER2-POSITIVE

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

HER2-positive

Get alerted when new HER2-positive trials appear

New drug zanidatamab aims to shrink early breast cancer tumors before surgery